Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
One in Six Globally Concerned About Colorectal Cancer Screening Costs 2024-05-31 08:00
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer 2024-05-31 07:19
LumaCina announces availability of Oral Morphine pain medication for New Zealanders 2024-05-31 05:17
Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research 2024-05-30 20:57
Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata 2024-05-30 07:05
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities 2024-05-29 22:00
Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human Genetics Conference - ESHG 2024 2024-05-29 17:55
Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024 2024-05-29 17:35
Frost & Sullivan Reported The Fourth Revolutionary Wave of Biologics Manufacturing: CDMOs Empower Large-scale Production of Biologics 2024-05-29 14:08
Spectacular advances creating a revolution in the diagnosis and treatment of male infertility 2024-05-29 12:42
US-Based Neurobiotic Leader Bened Life Launches Global Expansion with Neuralli™ MP 2024-05-29 10:00
US-Based Neurobiotic Leader Bened Life enters Japan market with Neuralli™ MP 2024-05-29 10:00
TREEFROG THERAPEUTICS PICKS-UP BEST POSTER AWARD AT THE INTERNATIONAL SOCIETY FOR CELL & GENE THERAPY (ISCT) ANNUAL MEETING FOR THEIR CELL THERAPY PROGRAM IN PARKINSON'S DISEASE 2024-05-29 06:00
Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects 2024-05-28 21:00
Turn Biotechnologies Signs Global Licensing Agreement with HanAll Biopharma to Develop Eye and Ear Therapies 2024-05-28 19:00
Stavian Chemical Ranks 17th in ICIS Top 100, Signaling Strong Growth Amid Global Market Challenges 2024-05-28 10:00
Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA 2024-05-28 08:00
Telix Submits NDA for New Prostate Cancer Imaging Agent 2024-05-27 07:21
Critical need for doctors to counsel couples on potential genetic burden in offspring of older dads 2024-05-26 15:59
YS Biopharma Announces Name Change to LakeShore Biopharma 2024-05-24 19:30
1 14 15 16 17 18 229